Filing Details

Accession Number:
0001127602-22-008258
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-04 16:13:30
Reporting Period:
2022-03-03
Accepted Time:
2022-03-04 16:13:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100682 Charles River Laboratories International Inc. CRL Services-Commercial Physical & Biological Research (8731) 061397316
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1650274 Ross David Smith 251 Ballardvale Street
Wilmington MA 01887
Corporate Executive Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-03 3,846 $109.34 29,665 No 4 M Direct
Common Stock Acquisiton 2022-03-03 3,304 $144.67 32,969 No 4 M Direct
Common Stock Acquisiton 2022-03-03 1,815 $179.66 34,784 No 4 M Direct
Common Stock Disposition 2022-03-03 3,825 $281.49 30,959 No 4 S Direct
Common Stock Disposition 2022-03-03 2,606 $282.56 28,353 No 4 S Direct
Common Stock Disposition 2022-03-03 1,289 $283.41 27,064 No 4 S Direct
Common Stock Disposition 2022-03-03 858 $284.58 26,206 No 4 S Direct
Common Stock Disposition 2022-03-03 387 $285.16 25,819 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2022-03-03 3,846 $0.00 3,846 $109.34
Common Stock Stock Options (Right to Buy) Disposition 2022-03-03 3,304 $0.00 3,304 $144.67
Common Stock Stock Options (Right to Buy) Disposition 2022-03-03 1,815 $0.00 1,815 $179.66
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-02-23 2023-02-23 No 4 M Direct
3,305 2020-02-22 2024-02-22 No 4 M Direct
5,446 2021-05-29 2030-05-29 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $280.98 to $281.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from $281.98 to $282.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $283.00 to $283.7. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $284.28 to $284.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $285.09 to $285.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.